Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease

NCT07166588 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT07166588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07166588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 20, 2021
Completion date
December 31, 2028
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd), ibd (inflammatory bowel disease), ulcerative colitis (uc)